Amicus Therapeutics to Present at Goldman Sachs 38th Annual Global Healthcare Conference
Jun 07, 2017 11:30 am UTC| Business
CRANBURY, N.J., June 07, 2017 -- Amicus Therapeutics, Inc. (Nasdaq:FOLD) announced today that John F. Crowley, Chairman and Chief Executive Officer, will participate in a corporate overview and fireside chat at the...
Jun 07, 2017 11:07 am UTC| Business
Dublin, June 07, 2017 -- Research and Markets has announced the addition of the "U.S. Pet Market Outlook, 2017-2018" report to their offering. Pet Market Outlook, Packaged Facts...
Jun 07, 2017 11:01 am UTC| Business
- OBE2109 is a GnRH receptor antagonist currently in development as both a stand-alone treatment and with add-back therapy designed to address the needs of endometriosis and uterine fibroid patients - Geneva,...
Lyfebulb and Novo Nordisk team up again to advance entrepreneur innovation in diabetes management
Jun 07, 2017 11:00 am UTC| Business
BAGSVRD, Denmark and NEW YORK, June 07, 2017 -- For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively...
Jun 07, 2017 11:00 am UTC| Business
HOPKINTON, Mass., June 07, 2017 -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH) announced today that an abstract regarding its lead STING agonist candidate was published at the 2017 American Society of Clinical...
Jun 07, 2017 11:00 am UTC| Business
REHOVOT, Israel, June 07, 2017 -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced that Kamada and Shire have agreed that the...
Mesa Labs Reports Record Net Income and Adjusted Net Income
Jun 07, 2017 11:00 am UTC| Business
LAKEWOOD, Colo., June 07, 2017 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record net income and adjusted net income for the year ended March 31, 2017. Highlights for...